Clinical & Pharmaceutical Solutions through Analysis
15 - 18 April, 2015
Renaissance Shanghai Pudong Hotel, Shanghai, China
Where Technology and Solutions Meet
Where East Meets West
|
CPSA Shanghai 2015Connecting the Dots:
|
# | Class | Author | Title |
---|---|---|---|
101 | GEN | Jianming Cao | Development of a High Sensitivity Quantitative SPE-LC/MS/MS Assay for Bradykinin in Human Plasma Using IonKey /MS Technology |
102 | GEN | Erin Chambers | Practical Considerations for LC/MS Bioanalysis of Proteins via the Surrogate Peptide Approach |
103 | GEN | Fuxin Chen | Determination of Natamycin Content in Cake Using Ultra Performance Liquid Chromatography-Mass/Mass Spectrometry |
104 | GEN | Tao Chen | Quantitative Analysis of OATP1B1 in Human Hepatocytes of Chinese Population Using Liquid Chromatography Tandem Mass Spectrometry |
105 | YSE | Jia Chen | Development of a Physiologically-based pharmacokinetic model to predict systemic and cerebrospinal icotinib exposure in cancer patients |
106 | YSE | Kan Chen | Is incidence of skin rash driven by peak concentration or wild type EGFR IC50 cover by pharmacokinetics for EGFR-TKIs? |
107 | YSE | Jia Chen | Population pharmacokinetic/pharmacodynamic/survival modeling analysis of icotinib in Chinese non-small cell lung cancer subjects |
108 | GEN | Wenqi Cui | Quantitative determination of Nucleoside Triphosphate in Rat liver using liquid chromatography–tandem mass spectrometry |
109 | YSE | Xinge Cui | Quantitative determination of Nucleoside Triphosphate in Rat liver using liquid chromatography–tandem mass spectrometry |
110 | YSE | Ziru Dai | Characterization of a highly selective ratiometric two-photon fluorescent probe for human cytochrome P450 1A and its biological applications |
111 | YSE | Jiajia Dong | Comparative disposition of intravenous catechols, derived from Salvia miltiorrhiza roots (Danshen), in rats and mechanisms governing their systemic exposure |
112 | YSE | Chaoying Hu | Single and Multiple Dose Pharmacokinetics, pharmacodynamics and safety of darapladib (a novel Lp-PLA2 enzyme inhibitor) in healthy Chinese subjects |
113 | GEN | Liang Huang | Investigation on ISR failure and the subsequent solutions to overcome the assay variability |
114 | GEN | Bo Li | What Quality of a Commercial Kit (Immunoassay) Needed ——Key parameters in a method for quantitative determination of target protein |
115 | YSE | Jerry Li | Adaptation of An in Vitro Model for Assessing the Reactivity of Acyl Glucuronides in Drug Discovery |
116 | YSE | Yang Liu | A mechanism-based model to describe oral glucose tolerance test data in Chinese type 2 diabetics |
117 | YSE | Xinwei Liu | Colonic Metabolites of Flavonols in Rats and Dogs after Oral Administration of GBE50, A Standardized Ginkgo biloba Leaf Extract |
118 | YSE | Cai Liu | Human Cytochrome P450 Enzymes and Hepatic Microsomal Thiol Methyltransferase Involved in Stereoselective Formation and Methylation of Pharmacologically Active Metabolite of Clopidogrel |
119 | GEN | Russell Mortishire-Smith | High Sensitivity Bioanalysis for Small Drug-Like Compounds in Human Plasma using Microflow LC and High Resolution Mass Spectrometry |
120 | GEN | Long Na | Evaluation of drug-induced hepatotoxicity with five biomarkers in sandwich cultured rat hepatocytes |
121 | GEN | Lirui Qiao | Applying LC/MS Natural Product Application Solution with UNIFI for the Identification of the Chemical and Herbal Components from an Unknown Traditional Chinese Medicine Product |
122 | GEN | Suzi Qin | Extraction of Telmisartan from Human Plasma Utilizing Cleanert SLE Plate with High Capacity |
123 | INN | Gary Valaskovic | Ease-of-use and sensitivity with nanospray: An integrated chip-based solution incorporating column temperature control, long columns, and nebulization. |
124 | GEN | Yi Tao | Development and Validation of an HPLC-MS/MS Method for Determination of Suramin in Monkey Plasma |
125 | YSE | Xun Tao | Intestinal Lymphatic Absorption into Consideration When Constructing Physiologically Based Pharmacokinetic Model (PBPK) |
126 | GEN | Gary Valaskovic | PicoFuze: Integration enables high-flow nanospray/microspray with conventional LC-ESI-MS |
127 | GEN | Dan Wang | Aristolochic acid I associated target identified by a monoclonal antibody against aristolochic acid I and II using immunoprecipitation and LC-MS/MS |
128 | GEN | Wan Wang |
Comparison of Various Sample Pretreatment Methods for Monitoring Arachidonic Acid in Plasma |
129 | YSE | Jing-Jing Wu | Characterization of gomisin A as a novel isoform-specific probe for selective detection of human cytochrome P450 3A4 |
130 | YSE | Zhixiong Xiang | Evaluation of the relative bioavailability of dabigatran etexilate mesylate in beagle dogs |
131 | GEN | Ling Xu | An LC/MS/MS Based Strategy for Quantification of Monoclonal Antibodies and Antibody-conjugated Drugs for Developing Antibody Drug Conjugates |
132 | YSE | Yumei Yan | Impact of incubation time on determination of unbound fractions in blood and brain homogenate |
133 | GEN | Xingxin Yang | Development of an Efficient Screening Method for Screening Potential Bioactive Compounds Binding to Mitochondria from Herbal Medicines by Combining Centrifugal Ultrafiltration with Liquid Chromatography/Mass Spectrometry |
134 | INN | Hui Wang | Development and Validation of LC-MS/MS Method for the Quantitation of Infliximab in Human Serum |
135 | YSE | Nating Zhang | Systemic exposure to and disposition of phthalides from Ligusticum chuanxiong rhizomes and Angelica sinensis roots after intravenous administration of XueBiJing injection in human subjects and rats |
136 | YSE | Jinqiang Zhang | Utilization of MDCK permeability and short oral absorption model for GI restricted drug discovery |
137 | YSE | Xin Zheng |
A simplification of population pharmacokinetic/pharmacodynemic model based time-dependent kinetics of Red Blood Cell (RBC) binding model and its application to drug CPRC-1 in human |
138 | YSE | Chenchun Zhong | Chemical Profiling of Ginkgo Biloba Leaves and Extracts |
139 | GEN | Lei Zhou | Oxidative and Reductive Activation of Nimesulide: Possibly Irrelevant with Hepatotoxicity |
140 | GEN | Yunting Zhu | In Vitro and In Vivo Metabolism of TPN729 and Assessment of Its Drug-Drug Interaction Potential |
141 | YSE | Dan Wu | A simple, rapid and reliable liquid chromatography-mass spectrometry method for determination of methotrexate in human plasma and its application to therapeutic drug monitoring |
142 | GEN | Tony Chen | In silico Modeling Can Predict the Unforeseen Renal Failure Caused by SGX523, a c-MET Kinase Inhibitor |
143 | GEN | Ying Zhou | Population pharmacokinetics and Monte Carlo dosing simulation of HR7056 anesthesia in Chinese healthy subjects |
144 | GEN | Chen Chen | Organic Anion-Transporting Polypeptides Contribute to the Hepatic Uptake of Berberine |